Searched for: person:anf202
in-biosketch:true
Methotrexate and Interstitial Lung Disease-Reply
Shah, Jill T; Femia, Alisa
PMID: 39714817
ISSN: 2168-6084
CID: 5767302
Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study
Shaw, Katharina S; Hashemi, Kimberly B; Castillo, Rochelle L; Rainone, Elizabeth; Ho, Allen W; Kahn, Philip J; Oza, Vikash S; Femia, Alisa; Vleugels, Ruth Ann
PMID: 39142472
ISSN: 1097-6787
CID: 5726892
Non-steroidal Immune Modulating Therapies and Reduced Risk of Adverse Cardiovascular Events in Dermatomyositis and Polymyositis: A Cohort Study in the All of Us Research Program
Shah, Jill T; Shah, Keya T; Mandal, Soutrik; Garshick, Michael S; Femia, Alisa N
PMID: 39547326
ISSN: 1097-6787
CID: 5753952
Non-steroidal Immune Modulating Therapies and Reduced Risk of Adverse Cardiovascular Events in Dermatomyositis and Polymyositis: A Cohort Study in the All of Us Research Program
Shah, Jill T; Shah, Keya T; Mandal, Soutrik; Garshick, Michael S; Femia, Alisa N
PMID: 39547326
ISSN: 1097-6787
CID: 5753932
Clinical Application of New Risk-Based Cancer Screening in Patients With Dermatomyositis
Maderal, Andrea D; Femia, Alisa
PMID: 39320904
ISSN: 2168-6084
CID: 5766482
Response to "Systemic correlates of cutaneous manifestations of lupus erythematosus" [Letter]
Needle, Carli; Brinks, Anna; Kearney, Caitlin; Femia, Alisa; Lo Sicco, Kristen
PMID: 39030771
ISSN: 1365-4632
CID: 5732112
Serpentine supravenous hyperpigmentation in association with anti-TIF1-gamma antibody-positive myositis [Letter]
Richardson, William M; Zampella, John G; Meehan, Shane A; Femia, Alisa N
PMID: 39219025
ISSN: 1365-4632
CID: 5687562
Paradoxical granulomatous reaction to ustekinumab
Obijiofor, Chinemelum; Mazori, Daniel R.; Femia, Alisa N.; Flamm, Alexandra; Caplan, Avrom S.
Sarcoidosis is a multisystem disorder characterised by granulomatous inflammation affecting various organs. The skin is commonly involved and can serve as an initial indicator of disease. While the precise aetiology of sarcoidosis remains elusive, evidence suggests involvement of T-helper type (TH)-1 and TH-17 pathways. Psoriasis shares common inflammatory pathways with sarcoidosis, prompting the repurposing of biologic therapies approved for psoriasis for off-label treatment of cutaneous sarcoidosis. However, this approach has raised concerns due to the development of granulomatous eruptions in some patients. We present a case of a patient with psoriasis who was diagnosed with systemic sarcoidosis while on ustekinumab. We review previous cases of ustekinumab-associated sarcoidosis and discuss the challenges associated with utilising biologic agents originally intended for psoriasis treatment for sarcoidosis.
SCOPUS:85183672296
ISSN: 2768-6566
CID: 5700972
Alopecia areata and cardiovascular comorbidities: A cross-sectional analysis of the All of Us research program
Nohria, Ambika; Shah, Jill T; Desai, Deesha; Alhanshali, Lina; Ingrassia, Jenne; Femia, Alisa; Garshick, Michael; Shapiro, Jerry; Lo Sicco, Kristen I
PMCID:11107229
PMID: 38774345
ISSN: 2666-3287
CID: 5654542
Hospitalization and Continuity of Care in Anti-MDA5 Dermatomyositis
Richardson, William Mark; Shah, Jill T; Mazori, Daniel R; Caplan, Avrom S; Lo Sicco, Kristen I; Femia, Alisa N
PMCID:11024728
PMID: 38630455
ISSN: 2168-6084
CID: 5671502